Shreyaskumar Patel
About
Shreyaskumar Patel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, Shreyaskumar Patel has authored 260 papers receiving a total of 14.7k indexed citations (citations by other indexed papers that have themselves been cited), including 205 papers in Pulmonary and Respiratory Medicine, 107 papers in Oncology and 59 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shreyaskumar Patel's work include Sarcoma Diagnosis and Treatment (189 papers), Vascular Tumors and Angiosarcomas (62 papers) and Cardiac tumors and thrombi (56 papers). Shreyaskumar Patel is often cited by papers focused on Sarcoma Diagnosis and Treatment (189 papers), Vascular Tumors and Angiosarcomas (62 papers) and Cardiac tumors and thrombi (56 papers). Shreyaskumar Patel collaborates with scholars based in United States, United Kingdom and France. Shreyaskumar Patel's co-authors include Robert S. Benjamin, Peter W. T. Pisters, Raphael E. Pollock, Matthew T. Ballo, Gunar K. Zagars, Robert G. Maki, Lei L. Chen, Barry W. Feig, Haesun Choi and Homer A. Macapinlac and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Shreyaskumar Patel
249 papers receiving 14.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Shreyaskumar Patel United States | 63 | 10.9k | 6.0k | 3.5k | 3.2k | 2.7k | 260 | 14.7k | ||
| Axel Le Cesne France | 62 | 9.7k 0.9× | 7.1k 1.2× | 2.2k 0.6× | 2.7k 0.9× | 2.6k 0.9× | 265 | 14.6k | ||
| Angelo Paolo Dei Tos Italy | 67 | 10.9k 1.0× | 6.1k 1.0× | 3.4k 1.0× | 4.5k 1.4× | 2.4k 0.9× | 438 | 17.0k | ||
| Peter Hohenberger Germany | 57 | 9.0k 0.8× | 5.1k 0.9× | 3.8k 1.1× | 1.7k 0.5× | 2.0k 0.7× | 369 | 13.8k | ||
| Axel Le Cesne France | 56 | 7.9k 0.7× | 4.3k 0.7× | 2.1k 0.6× | 2.1k 0.7× | 1.9k 0.7× | 270 | 10.6k | ||
| Sylvie Bonvalot France | 54 | 9.3k 0.8× | 5.2k 0.9× | 3.2k 0.9× | 3.7k 1.2× | 2.7k 1.0× | 268 | 12.2k | ||
| Alessandro Gronchi Italy | 78 | 15.7k 1.4× | 7.3k 1.2× | 3.5k 1.0× | 7.5k 2.4× | 4.5k 1.7× | 469 | 19.4k | ||
| Jean‐Michel Coindre France | 73 | 12.4k 1.1× | 7.5k 1.3× | 1.9k 0.5× | 4.9k 1.5× | 4.0k 1.5× | 296 | 17.7k | ||
| Antoîne Italiano France | 67 | 9.2k 0.8× | 9.0k 1.5× | 2.6k 0.8× | 2.3k 0.7× | 2.1k 0.8× | 618 | 17.5k | ||
| Scott M. Schuetze United States | 43 | 6.4k 0.6× | 3.3k 0.6× | 1.3k 0.4× | 2.0k 0.6× | 1.5k 0.6× | 167 | 8.7k | ||
| Jonathan J. Lewis United States | 46 | 6.3k 0.6× | 3.6k 0.6× | 2.2k 0.6× | 2.8k 0.9× | 1.5k 0.5× | 86 | 10.0k |
Countries citing papers authored by Shreyaskumar Patel
Since
Specialization
Citations
This map shows the geographic impact of Shreyaskumar Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shreyaskumar Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shreyaskumar Patel more than expected).
Fields of papers citing papers by Shreyaskumar Patel
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Shreyaskumar Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shreyaskumar Patel. The network helps show where Shreyaskumar Patel may publish in the future.
Co-authorship network of co-authors of Shreyaskumar Patel
This figure shows the co-authorship network connecting the top 25 collaborators of Shreyaskumar Patel. A scholar is included among the top collaborators of Shreyaskumar Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shreyaskumar Patel. Shreyaskumar Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Czyż, Marcin, Michael Galgano, Shreyaskumar Patel, et al.. (2025). AO Spine Clinical Practice Recommendations: Current Systemic Oncological Treatments with the Largest Impact on Patients with Metastatic Spinal Disease. Global Spine Journal. 15(4). 1884–1889.
2.
Denu, Ryan A., Ahsan Farooqi, Davis R. Ingram, et al.. (2024). Impact of ATRX loss on survival and immune microenvironment in multiple sarcoma subtypes.. Journal of Clinical Oncology. 42(16_suppl). 11511–11511.
3.
Weiss, Aaron R., Safia K. Ahmed, Wendy Allen‐Rhoades, et al.. (2023). Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group. Journal of Adolescent and Young Adult Oncology. 12(5). 792–793.
4.
Jones, Robin L., Thomas J. Herzog, Shreyaskumar Patel, et al.. (2021). Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer. Cancer Medicine. 10(11). 3565–3574.
5.
Tarek, Nidale, Rabih Said, Clark R. Andersen, et al.. (2020). Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience. Cancers. 12(10). 2927–2927.
6.
Gounder, Mrinal M., Priscilla Merriam, Ravin Ratan, et al.. (2020). Real‐world outcomes of patients with locally advanced or metastatic epithelioid sarcoma. Cancer. 127(8). 1311–1317.
7.
Subbiah, Vivek, Salah-Eddine Lamhamedi-Cherradi, Branko Cuglievan, et al.. (2018). Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival. Clinical Cancer Research. 24(19). 4865–4873.
8.
Schvartsman, Gustavo, Michael J. Wagner, Behrang Amini, et al.. (2017). Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients. Scientific Reports. 7(1). 9519–9519.
9.
Livingston, J. Andrew, Diogo Diniz Gomes Bugano, Andrea Barbo, et al.. (2017). Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard. Scientific Reports. 7(1). 11836–11836.
10.
Demetri, George D., Margaret von Mehren, Robin L. Jones, et al.. (2015). Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial. Journal of Clinical Oncology. 34(8). 786–793.
11.
Corless, Christopher L., Karla V. Ballman, Cristina R. Antonescu, et al.. (2014). Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial. Journal of Clinical Oncology. 32(15). 1563–1570.
12.
Conter, Henry Jacob, Vancheswaran Gopalakrishnan, Vinod Ravi, et al.. (2014). Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience. Sarcoma. 2014. 1–6.
13.
Pappo, Alberto S., Shreyaskumar Patel, John Crowley, et al.. (2011). R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study. Journal of Clinical Oncology. 29(34). 4541–4547.
14.
Patel, Shreyaskumar. (2011). Managing progressive disease in patients with GIST: Factors to consider besides acquired secondary tyrosine kinase inhibitor resistance. Cancer Treatment Reviews. 38(5). 467–472.
15.
Chugh, Rashmi, J. Kyle Wathen, Shreyaskumar Patel, et al.. (2010). Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial. Clinical Cancer Research. 16(19). 4884–4891.
16.
Maki, Robert G., J. Kyle Wathen, Shreyaskumar Patel, et al.. (2007). Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002. Journal of Clinical Oncology. 25(19). 2755–2763.
17.
Lev, Dina, Caimiao Wei, Matthew T. Ballo, et al.. (2007). Optimizing Treatment of Desmoid Tumors. Journal of Clinical Oncology. 25(13). 1785–1791.
18.
Patel, Shreyaskumar. (2005). La era de la terapia molecular: redefiniendo el tratamiento de los tumores del estroma gastrointestinal. Gaceta Mexicana de Oncología. 4. 13–17.
19.
Patel, Shreyaskumar, Carl Plager, Nicholas E. Papadopoulos, & Robert S. Benjamin. (1995). Myxoid Malignant Fibrous Histiocytoma. American Journal of Clinical Oncology. 18(6). 528–531.
20.
Ransom, David, Shreyaskumar Patel, Gary L. Keeney, George D. Malkasian, & John H. Edmonson. (1990). Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy. Cancer. 66(6). 1091–1094.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Axel Le Cesne Breakdown of academic impact, for papers by Angelo Paolo Dei Tos Breakdown of academic impact, for papers by Peter Hohenberger Breakdown of academic impact, for papers by Axel Le Cesne Breakdown of academic impact, for papers by Sylvie Bonvalot Breakdown of academic impact, for papers by Alessandro Gronchi Breakdown of academic impact, for papers by Jean‐Michel Coindre Breakdown of academic impact, for papers by Antoîne Italiano Breakdown of academic impact, for papers by Scott M. Schuetze Breakdown of academic impact, for papers by Jonathan J. Lewis